Evidence map›Paper›PMID 39385554›Full record

ArticlePigment cell & melanoma research2025

Meeting Report From the 2023 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Philadelphia, PA, November 2023.

Rino S Seedor, Andrew E Aplin, Corine Bertolotto, Richard D Carvajal, Nigel Deacon, Katie Doble, Omid Hamid, Rizwan Haq, Miriam Kadosh, Shaheer Khan and 10 more

Abstract readConference Proceedings
PubMed Full text at PMC Publisher
In one paragraph

Article in Pigment cell & melanoma research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Rino S SeedorSidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-8494-3289
Andrew E AplinSidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-2734-3244
Corine BertolottoINSERM, Paris, France.
Richard D CarvajalNorthwell Health Cancer Institute, New Hyde Park, New York, USA.
Nigel DeaconPatient Advocate, British Columbia, Canada.
Katie DoblePatient Advocate, Denver, Colorado, USA.
Omid HamidThe Angeles Clinic and Research Institute, a Cedars-Sinai Affiliate, Los Angeles, California, USA.
Rizwan HaqDana-Farber Cancer Institute, Boston, Massachusetts, USA.
Miriam KadoshMelanoma Research Foundation, CURE OM, Washington, DC, USA.
Shaheer KhanNorthwell Health Cancer Institute, New Hyde Park, New York, USA.
Jacqueline KraskaMelanoma Research Foundation, CURE OM, Washington, DC, USA.
Jose LutzkySylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, USA.ORCID 0000-0002-9503-2130
Meredith McKeanSarah Cannon Research Institute, Nashville, Tennessee, USA.
Kamaneh MontazeriMass General Cancer Center, Boston, Massachusetts, USA.
Justin MoserHonorHealth Research Institute, Scottsdale, Arizona, USA.
Michael OnkenWashington University in St. Louis, St. Louis, Missouri, USA.ORCID 0000-0003-4082-1105
Marlana OrloffSidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.ORCID 0000-0001-9460-2587
Joseph J SaccoClatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK.ORCID 0000-0003-2591-9796
Keiran SmalleyMoffitt Cancer Center, Tampa, Florida, USA.ORCID 0000-0003-1089-9307
Sara M SeligMelanoma Research Foundation, CURE OM, Washington, DC, USA.

Funding

Melanoma Research Foundation
6 · The paper itself

Abstract

The 2023 Cure Ocular Melanoma (CURE OM) Global Science Meeting was held in Philadelphia on November 6, 2023. There is increased awareness and dedicated research in uveal melanoma (UM), but unmet needs remain in the prevention, detection, and treatment of UM. The purpose of this meeting was to provide an international forum for the exchange of research ideas, to allow for discussion of basic science as well as clinical research on UM, and to gather input about advocacy and patient needs.

Indexed as

MelanomaUveal NeoplasmsBiomedical ResearchHumansPhiladelphiaUveal Melanoma

Identifiers

PMID39385554
PMCPMC11967437

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.